205 related articles for article (PubMed ID: 23637606)
41. Effects of heparin administration on Trypanosoma brucei gambiense infection in rats.
Nishimura K; Shima K; Asakura M; Ohnishi Y; Yamasaki S
J Parasitol; 2005 Feb; 91(1):219-22. PubMed ID: 15856910
[TBL] [Abstract][Full Text] [Related]
42. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
[TBL] [Abstract][Full Text] [Related]
43. Developmentally regulated sensitivity of Trypanosoma brucei brucei to the cytotoxic effects of human high-density lipoprotein.
Moore DR; Smith A; Hager KM; Waldon R; Esko JD; Hajduk SL
Exp Parasitol; 1995 Sep; 81(2):216-26. PubMed ID: 7556564
[TBL] [Abstract][Full Text] [Related]
44. Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity.
Stephens NA; Hajduk SL
Eukaryot Cell; 2011 Aug; 10(8):1023-33. PubMed ID: 21705681
[TBL] [Abstract][Full Text] [Related]
45. Individual variation in levels of haptoglobin-related protein in children from Gabon.
Imrie HJ; Fowkes FJ; Migot-Nabias F; Luty AJ; Deloron P; Hajduk SL; Day KP
PLoS One; 2012; 7(11):e49816. PubMed ID: 23185445
[TBL] [Abstract][Full Text] [Related]
46.
Cooper A; Ilboudo H; Alibu VP; Ravel S; Enyaru J; Weir W; Noyes H; Capewell P; Camara M; Milet J; Jamonneau V; Camara O; Matovu E; Bucheton B; MacLeod A
Elife; 2017 May; 6():. PubMed ID: 28537557
[TBL] [Abstract][Full Text] [Related]
47. Endocytosis of a cytotoxic human high density lipoprotein results in disruption of acidic intracellular vesicles and subsequent killing of African trypanosomes.
Hager KM; Pierce MA; Moore DR; Tytler EM; Esko JD; Hajduk SL
J Cell Biol; 1994 Jul; 126(1):155-67. PubMed ID: 8027174
[TBL] [Abstract][Full Text] [Related]
48. A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans.
Vanhollebeke B; De Muylder G; Nielsen MJ; Pays A; Tebabi P; Dieu M; Raes M; Moestrup SK; Pays E
Science; 2008 May; 320(5876):677-81. PubMed ID: 18451305
[TBL] [Abstract][Full Text] [Related]
49. Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei.
Alsford S; Currier RB; Guerra-Assunção JA; Clark TG; Horn D
PLoS Pathog; 2014 May; 10(5):e1004130. PubMed ID: 24830321
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis of human African trypanosomiasis.
Van Meirvenne N
Ann Soc Belg Med Trop; 1992; 72 Suppl 1():53-6. PubMed ID: 1417169
[No Abstract] [Full Text] [Related]
51. [Distribution and spread of human African trypanosomiasis: value of genetic identification of the trypanosomes].
Truc P; Cuny G
Med Trop (Mars); 2001; 61(4-5):433-6. PubMed ID: 11803837
[TBL] [Abstract][Full Text] [Related]
52. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
[TBL] [Abstract][Full Text] [Related]
53. [Human serum trypanosome lytic factor and serum resistance-associated protein of trypanosome].
Li Z; Lun ZR
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Apr; 26(2):136-40, 145. PubMed ID: 24812818
[TBL] [Abstract][Full Text] [Related]
54. Development of multiplex serological assay for the detection of human African trypanosomiasis.
Nzou SM; Fujii Y; Miura M; Mwau M; Mwangi AW; Itoh M; Salam MA; Hamano S; Hirayama K; Kaneko S
Parasitol Int; 2016 Apr; 65(2):121-7. PubMed ID: 26519611
[TBL] [Abstract][Full Text] [Related]
55. Human African trypanosomiasis: connecting parasite and host genetics.
Garcia A; Courtin D; Solano P; Koffi M; Jamonneau V
Trends Parasitol; 2006 Sep; 22(9):405-9. PubMed ID: 16837245
[TBL] [Abstract][Full Text] [Related]
56. Trypanosome lytic factors: novel mediators of human innate immunity.
Raper J; Portela MP; Lugli E; Frevert U; Tomlinson S
Curr Opin Microbiol; 2001 Aug; 4(4):402-8. PubMed ID: 11495802
[TBL] [Abstract][Full Text] [Related]
57. Conserved sequence of the TgsGP gene in Group 1 Trypanosoma brucei gambiense.
Gibson W; Nemetschke L; Ndung'u J
Infect Genet Evol; 2010 May; 10(4):453-8. PubMed ID: 20302972
[TBL] [Abstract][Full Text] [Related]
58. [The controversial story of the human trypanolytic factor].
Pays E; Vanhollebeke B
Med Sci (Paris); 2008 Oct; 24(10):792-3. PubMed ID: 18950568
[No Abstract] [Full Text] [Related]
59. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
Lüscher A; de Koning HP; Mäser P
Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
[TBL] [Abstract][Full Text] [Related]
60. Drug transport and drug resistance in African trypanosomes.
Mäser P; Lüscher A; Kaminsky R
Drug Resist Updat; 2003 Oct; 6(5):281-90. PubMed ID: 14643298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
